| Titin cardiomyopathy leads to altered mitochondrial energetics, increased fibrosis and long-term life-threatening arrhythmias JAJ Verdonschot, MR Hazebroek, KWJ Derks, A Barandiarán Aizpurua, ... European heart journal 39 (10), 864-873, 2018 | 162 | 2018 |
| Relevance of cardiac parvovirus B19 in myocarditis and dilated cardiomyopathy: review of the literature J Verdonschot, M Hazebroek, J Merken, Y Debing, R Dennert, ... European journal of heart failure 18 (12), 1430-1441, 2016 | 151 | 2016 |
| A mutation update for the FLNC gene in myopathies and cardiomyopathies JAJ Verdonschot, EK Vanhoutte, GRF Claes, ... Human mutation 41 (6), 1091-1111, 2020 | 109 | 2020 |
| Prognostic relevance of gene-environment interactions in patients with dilated cardiomyopathy: applying the MOGE (S) classification MR Hazebroek, S Moors, R Dennert, A van den Wijngaard, I Krapels, ... Journal of the American College of Cardiology 66 (12), 1313-1323, 2015 | 103 | 2015 |
| The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE … JGF Cleland, JP Ferreira, B Mariottoni, P Pellicori, J Cuthbert, ... European heart journal 42 (6), 684-696, 2021 | 93 | 2021 |
| Immunosuppressive therapy improves both short-and long-term prognosis in patients with virus-negative nonfulminant inflammatory cardiomyopathy J Merken, M Hazebroek, P Van Paassen, J Verdonschot, V Van Empel, ... Circulation: Heart Failure 11 (2), e004228, 2018 | 93 | 2018 |
| Proteomic bioprofiles and mechanistic pathways of progression to heart failure: the HOMAGE study JP Ferreira, J Verdonschot, T Collier, P Wang, A Pizard, C Bär, ... Circulation: Heart Failure 12 (5), e005897, 2019 | 82 | 2019 |
| Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences JAJ Verdonschot, M Merlo, F Dominguez, P Wang, MTHM Henkens, ... European Heart Journal 42 (2), 162-174, 2021 | 80 | 2021 |
| Genetic architecture of acute myocarditis and the overlap with inherited cardiomyopathy AS Lota, MR Hazebroek, P Theotokis, R Wassall, S Salmi, BP Halliday, ... Circulation 146 (15), 1123-1134, 2022 | 74 | 2022 |
| Implications of genetic testing in dilated cardiomyopathy JAJ Verdonschot, MR Hazebroek, IPC Krapels, MTHM Henkens, A Raafs, ... Circulation: Genomic and Precision Medicine 13 (5), 476-487, 2020 | 71 | 2020 |
| Clinical phenotype and genotype associations with improvement in left ventricular function in dilated cardiomyopathy JAJ Verdonschot, MR Hazebroek, P Wang, S Sanders-van Wijk, ... Circulation: Heart Failure 11 (11), e005220, 2018 | 64 | 2018 |
| Age is the main determinant of COVID-19 related in-hospital mortality with minimal impact of pre-existing comorbidities, a retrospective cohort study M Henkens, AG Raafs, JAJ Verdonschot, M Linschoten, M Van Smeden, ... BMC geriatrics 22 (1), 184, 2022 | 61 | 2022 |
| Proteomic and mechanistic analysis of spironolactone in patients at risk for HF JP Ferreira, J Verdonschot, P Wang, A Pizard, T Collier, FZ Ahmed, ... Heart Failure 9 (4), 268-277, 2021 | 55 | 2021 |
| Effects of spironolactone on serum markers of fibrosis in people at high risk of developing heart failure: rationale, design and baseline characteristics of a proof‐of‐concept … P Pellicori, JP Ferreira, B Mariottoni, HP Brunner‐La Rocca, FZ Ahmed, ... European journal of heart failure 22 (9), 1711-1723, 2020 | 51 | 2020 |
| Value of speckle tracking–based deformation analysis in screening relatives of patients with asymptomatic dilated cardiomyopathy JAJ Verdonschot, JJ Merken, HP Brunner-La Rocca, MR Hazebroek, ... Cardiovascular Imaging 13 (2_Part_2), 549-558, 2020 | 49 | 2020 |
| Left atrial strain has superior prognostic value to ventricular function and delayed-enhancement in dilated cardiomyopathy AG Raafs, JL Vos, MTHM Henkens, BO Slurink, JAJ Verdonschot, ... Cardiovascular Imaging 15 (6), 1015-1026, 2022 | 44 | 2022 |
| Natural History of MYH7-Related Dilated Cardiomyopathy F De Frutos, JP Ochoa, M Navarro-Peñalver, A Baas, JV Bjerre, E Zorio, ... Journal of the American College of Cardiology 80 (15), 1447-1461, 2022 | 42 | 2022 |
| The combination of carboxy‐terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic … AG Raafs, JAJ Verdonschot, MTHM Henkens, BP Adriaans, P Wang, ... European journal of heart failure 23 (6), 933-944, 2021 | 42 | 2021 |
| Role of targeted therapy in dilated cardiomyopathy: the challenging road toward a personalized approach JAJ Verdonschot, MR Hazebroek, JS Ware, SK Prasad, SRB Heymans Journal of the American Heart Association 8 (11), e012514, 2019 | 42 | 2019 |
| Clinical risk score to predict pathogenic genotypes in patients with dilated cardiomyopathy L Escobar-Lopez, JP Ochoa, A Royuela, JAJ Verdonschot, M Dal Ferro, ... Journal of the American College of Cardiology 80 (12), 1115-1126, 2022 | 33 | 2022 |
